Get the Stockscreener App
1.16
3.57%
0.04
Heron Therapeutics Inc stock is traded at $1.16, with a volume of 769.86K.
It is up +3.57% in the last 24 hours and down -2.52% over the past month.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
See More
Previous Close:
$1.12
Open:
$1.12
24h Volume:
769.86K
Relative Volume:
0.45
Market Cap:
$212.70M
Revenue:
$137.74M
Net Income/Loss:
$-27.97M
P/E Ratio:
-7.25
EPS:
-0.16
Net Cash Flow:
$-9.61M
1W Performance:
+9.43%
1M Performance:
-2.52%
6M Performance:
-36.61%
1Y Performance:
+0.00%
1-Day Range:
$1.11
$1.17
1-Week Range:
$1.05
$1.17
52-Week Range:
$0.9999
$2.68
Heron Therapeutics Inc Stock (HRTX) Company Profile
Name
Heron Therapeutics Inc
Sector
Industry
Phone
(858) 251-4400
Address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
Compare HRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.16 | 205.37M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Initiated | H.C. Wainwright | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-23-24 | Initiated | CapitalOne | Overweight |
| Mar-13-24 | Reiterated | Needham | Buy |
| May-27-20 | Initiated | Guggenheim | Buy |
| Feb-20-20 | Reiterated | Needham | Buy |
| Jan-16-19 | Reiterated | Needham | Buy |
| Apr-05-18 | Initiated | Evercore ISI | Outperform |
| Mar-19-18 | Reiterated | Mizuho | Buy |
| Mar-01-18 | Reiterated | Needham | Buy |
| Jan-03-18 | Initiated | Leerink Partners | Outperform |
| Sep-27-17 | Initiated | Northland Capital | Outperform |
| Feb-27-17 | Initiated | Needham | Buy |
| Oct-26-16 | Initiated | Aegis Capital | Buy |
| Sep-06-16 | Resumed | Lake Street | Buy |
| May-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Dec-10-15 | Initiated | Lake Street | Buy |
| Sep-23-15 | Reiterated | Leerink Partners | Outperform |
| Sep-02-15 | Initiated | BofA/Merrill | Buy |
| Aug-03-15 | Reiterated | Brean Capital | Buy |
| Jun-30-15 | Reiterated | JMP Securities | Mkt Outperform |
| Jun-19-15 | Reiterated | Leerink Partners | Outperform |
| Aug-07-14 | Initiated | Noble Financial | Buy |
View All
Heron Therapeutics Inc Stock (HRTX) Latest News
Is Heron Therapeutics Inc a good long term investmentMorning Star Patterns & Free Long-Term Investment Planning - earlytimes.in
What analysts say about Heron Therapeutics Inc AXD2 stockMarket Sentiment Surveys & Build a Dividend-Powered Portfolio - earlytimes.in
Is Heron Therapeutics Inc. stock gaining market sharePortfolio Gains Summary & Low Risk High Win Rate Stock Picks - BỘ NỘI VỤ
Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Trading Action: Can Heron Therapeutics Inc. stock surprise with earnings upsideQuarterly Trade Report & High Accuracy Swing Entry Alerts - BỘ NỘI VỤ
Heron Therapeutics, Inc. $HRTX Shares Sold by Orchard Capital Management LLC - MarketBeat
Jefferies Financial Group Inc. Acquires 344,200 Shares of Heron Therapeutics, Inc. $HRTX - MarketBeat
Is Heron Therapeutics Inc AXD2 a good long term investmentFundamental Strength Indicators & High Yield Stock Picks - earlytimes.in
Heron Therapeutics, Inc. (HRTX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Can Heron Therapeutics Inc. (AXD2) stock attract ESG investmentsJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Why Heron Therapeutics Inc. (AXD2) stock remains stableWeekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
How cyclical is Heron Therapeutics Inc. (AXD2) stock compared to rivalsEarnings Miss & Daily Technical Stock Forecast Reports - newser.com
How Heron Therapeutics Inc. (AXD2) stock responds to bond marketInsider Buying & AI Enhanced Trading Signals - newser.com
How Heron Therapeutics Inc. (AXD2) stock moves in volatile trading sessionsJuly 2025 Retail & Short-Term Trading Alerts - newser.com
Heron Therapeutics Inc. stock daily chart insightsRecession Risk & Weekly High Potential Stock Alerts - newser.com
Is Heron Therapeutics Inc. (AXD2) stock prepared for digital transitionQuarterly Market Summary & Stepwise Entry and Exit Trade Signals - newser.com
Heron Therapeutics Inc. stock prediction for this weekTrade Entry Report & Expert Approved Trade Ideas - newser.com
Ready to Jump After Recent Trade: Heron Therapeutics Inc (HRTX) - Setenews
Ranking Heron Therapeutics Inc. among high performing stocks via toolsExit Point & Low Drawdown Trading Strategies - newser.com
Will Heron Therapeutics Inc. stock benefit from automationTreasury Yields & Fast Moving Stock Trade Plans - newser.com
Why Heron Therapeutics Inc. (AXD2) stock could rally stronglyMarket Sentiment Summary & Daily Chart Pattern Signal Reports - newser.com
Heron Therapeutics Inc Stock (HRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):